Oramorph

Oramorph contains morphine, a strong pain reliever, used to treat severe long-term pain.

Form
oraaliliuos
Strength
20 mg/ml
Active Ingredient
Morphine sulphate pentahydrate
Manufacturer
L.Molteni & C.dei F.lli Alitti Società di Esercizio S.p.A.

How to Use

Dosage

Always take this medicine exactly as your doctor has told you. Your doctor will decide your dose.

Method

Take the oral solution by mouth. Use the provided syringe or dropper to measure your exact dose.

Important

Do not take more than the dose prescribed by your doctor. Taking too much can be very dangerous.

Possible Side Effects

COMMON
  • Drowsiness
  • Tiredness
  • Constipation
  • Nausea (feeling sick)
  • Vomiting (being sick)
  • Difficulty urinating
  • Small pupils
RARE
  • Itching
  • Low blood pressure (can cause dizziness)
  • Breathing difficulties or tight airways
  • Spasms in bile or urinary tracts
  • General feeling of being unwell
  • Increased pain sensitivity
  • Sweating
  • Dry mouth
  • Sleep apnea (breathing stops during sleep)
  • Withdrawal symptoms or dependence (if you stop the medicine)
  • Pancreas or gallbladder problems (symptoms like severe upper stomach pain, nausea, vomiting, or fever)

Important Warnings

  • Do not take Oramorph if you are allergic to morphine or any other ingredients in it.
  • Do not take if you have a serious stomach illness or if your bowels are not working.
  • Do not take if you have acute poisoning or a severe asthma attack.
  • Stop Oramorph and get medical help right away if you get blisters, widespread skin peeling, or pus-filled spots with fever. These are signs of a severe skin reaction.
  • This medicine contains morphine, which is an opioid. Using it often can lead to tolerance (it works less), dependence (your body needs it), or addiction (you feel you can't stop). Taking too much can be life-threatening. Talk to your doctor if you are worried about addiction.
Show 11 more warnings
  • Tell your doctor if you have other health issues like asthma or breathing problems, an enlarged prostate, overactive thyroid, liver or kidney disease, gallstones, epilepsy, bowel disease, sickle cell disease, or a history of drug or alcohol problems.
  • Oramorph can cause breathing to stop or slow down during sleep (sleep apnea). If you or others notice this or if you are very sleepy during the day, tell your doctor.
  • If you feel more pain even with higher doses of Oramorph, talk to your doctor.
  • Contact your doctor if you have severe upper stomach pain that goes to your back, nausea, vomiting, or fever. These could be signs of pancreas or gallbladder problems.
  • Talk to your doctor if you feel weak, tired, lose appetite, have nausea, vomiting, or low blood pressure. These could be signs of problems with your adrenal glands.
  • Tell your doctor if you notice changes in your sex drive, have trouble getting pregnant/getting an erection, or miss periods, as Oramorph can affect hormones.
  • Tell your doctor or pharmacist about all other medicines you take. Taking Oramorph with some medicines, like sedatives, can cause severe drowsiness, breathing problems, or coma.
  • Do not drink alcohol while taking Oramorph, as it can cause serious breathing problems.
  • If you are pregnant or breastfeeding, talk to your doctor before using Oramorph. Using it for a long time during pregnancy can cause withdrawal symptoms in the baby. Morphine can pass into breast milk.
  • This medicine can make you less alert, so be careful when driving or using machines.
  • Some Oramorph solutions contain sugar and alcohol, or preservatives. If you have diabetes, alcohol dependence, or any allergies to preservatives, tell your doctor. Some solutions also contain sodium benzoate, which can increase the risk of jaundice in newborns.

Use in Elderly Patients

Category C

Suitable for older adults, with specific precautions. Sedative. Reduce the dose already in mild renal impairment. Avoid use in severe renal impairment. Increases the risk of confusion and falling. Need for laxative is often necessary. (updated 24.3.2025)